Titlebook: Childhood Leukemia: Present Problems and Future Prospects; Proceedings of the S Noboru Kobayashi,Tai Akera,Shuki Mizutani Conference procee

plasma

铁塔等

Immunological Properties of Hematopoietic Malignancies in Childhoode histologically subtyped into lymphoblastic (LB,39%), Burkitt’s lymphoma (BL,31%), and large cell (LA,28%) types. BLs were all positive for pan B markers (immunoglobulins and CD 19/20/22), as well as the activated B-cell antigens, CD 10 and B5. However, BLs were phenotypically heterogenous with the

母猪

Polymerase Chain Reaction Studies on Chronic Myelogenous Leukemias and Detection of Residual Ph1 Clo the polymerase chain reaction (PCR). In all samples the bcr-abl chimeric mRNA was detected. Seven cases showed bcr exon 2/abl exon 2 (b2-a) chimeric mRNA, 15 cases showed bcr exon 3/abl exon 2 (b3-a) chimeric mRNA, and 12 cases showed both of these mRNAs. None of the 34 samples with expression of b

thyroid-hormone

Lineage-Specific Classification of Childhood Leukemia and its Clinical Implicationsrthern blot analyses to define the lineage-specific classification of childhood leukemia. Phenotypically, they were divided into B lineage (62.6%), T lineage (9.8%), nonlymphoid (14.3%), and uncertain lineage (13.3%). Two of the B-lineage ALL and two of the T-lineage ALL studied did not show immunog

裂缝

HEAVY

figure

Long-Term Survivors of Leukemia and Late Effects: A Report from the Registry of Long-Term Survivors ual patients are concerned, some patients, even nonrelapsed ones, have apparent abnormalities. However, as a population, significant abnormalities are not apparent. A large proportion of the patients in this study were treated before current treatment procedures came into widespread use, and this tr

PATRI

Therapy of Childhood Leukemia: Understanding Success and Failuregnancy. From the cautious use of single—agent chemotherapy in the 1950s, therapy has evolved to include the aggressive use of multiple agents. The results have been a progressive increase in remission frequency and remission duration. However, the most important outcome has been the increased cure r

fatty-acids

Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studieshe most important predicting factor for success or failure. The acute leukemias still need adequate management, no matter how the geno- or phenotype of the leukemic clone is characterized. Enforced by the antileukemic efficacy of improved therapy, some risk factors of the past have lost importance,

会犯错误